BOI:EPA
Boiron USA
19,20 €
arrow_upward
+0,79%(+0,15) 1D
13 ნოე, 17:35:27 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
19,25 €
High
19,25 €
Low
18,95 €
Mkt. cap
330,69 მლნ.
Avg. vol.
4,88 ათ.
Volume
1,71 ათ.
P/E ratio
12,73
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 მლნ.
No. of employees
3 ათ.
Open
19,25 €
High
19,25 €
Low
18,95 €
Mkt. cap
330,69 მლნ.
Avg. vol.
4,88 ათ.
Volume
1,71 ათ.
P/E ratio
12,73
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
The Motley Fool
·
23 წუთის წინ
Should You Invest Now or Wait Until 2027? Here's What a Century of History Says.
Rich Picks Daily
·
27 წუთის წინ
Anthropic IPO puts more than $900 billion in AI spending commitments i…
TheStreet
·
2 საათის წინ
Goldman Sachs reset S&P 500 price target for 2027
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron USA
CEO-
Employees2,62 ათ.
Founded7 ივნ. 1932
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteboiron.fr